The 9th SAPA Healthcare Investment Forum & Roadshow (HIFnR 2026) was recently held, bringing together Chipscreen Biosciences and 200 experts and industry leaders from global pharmaceutical and biotechnology companies, investment institutions, consulting firms, and the artificial intelligence sector. Participants engaged in in-depth discussions on biopharmaceutical innovation, cross-border collaboration, investment trends, AI-enabled innovation, and corporate financing, exploring new opportunities and future directions for the global life sciences industry.